In the active areas of MS lesions, we observed a significant increase in the proportion of OLs expressing high levels of ATF4 (49% ± 4.9) compared to control (7% ± 4) (Fig. 1D, E). This evidence concerns the gene ATF4 and myeloid sarcoma.